Nanomedicines from the patient perspective – 30 years after PEGylated liposomal doxorubicin
Year: 2026
Type: article
Source: Journal of Controlled Release
Institutions: University of Toronto, University of Ottawa, Ovarian Cancer Canada
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W7161753686
